(Q42250948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Pierre-Yves Bochud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Martin Lagging

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

L Covolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Donato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Negro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

G Fattovich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

5 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

322-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308755%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

2 March 2020

cites work

1 reference

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients

21 January 2018

1 reference

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference

Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

Faldaprevir and deleobuvir for HCV genotype 1 infection.

21 January 2018

1 reference

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

21 January 2018

1 reference

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

21 January 2018

1 reference

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C.

21 January 2018

1 reference

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms

21 January 2018

1 reference

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

21 January 2018

1 reference

Association between interleukin-28B-related genetic variants and liver histopathology differs between hepatitis C virus genotypes.

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

21 January 2018

1 reference

Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.

21 January 2018

1 reference

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.

21 January 2018

1 reference

Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

21 January 2018

1 reference